Young-Chul Park
Chief Executive Officer bei MOA LIFE PLUS CO. LTD.
Vermögen: 14 Mio $ am 31.03.2024
Profil
Young-Chul Park is currently the CEO, Director & Head-Management at BL Pharmtech Corp.
and the Chief Executive Officer & Director at BL Corp.
(South Korea).
Previously, he held the position of Chief Executive Officer & Director at TCM Biosciences, Inc. Dr. Park holds a doctorate degree from Yonsei University and an undergraduate degree from Kyung Hee University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MOA LIFE PLUS CO. LTD.
22,45% | 16.04.2024 | 7 244 268 ( 22,45% ) | 14 Mio $ | 31.03.2024 |
BL PHARMTECH CORP.
0,18% | 18.03.2024 | 161 742 ( 0,18% ) | 58 149 $ | 31.03.2024 |
Aktive Positionen von Young-Chul Park
| Unternehmen | Position | Beginn |
|---|---|---|
| MOA LIFE PLUS CO. LTD. | Chief Executive Officer | - |
| BL PHARMTECH CORP. | Director/Board Member | - |
Ehemalige bekannte Positionen von Young-Chul Park
| Unternehmen | Position | Ende |
|---|---|---|
TCM Biosciences, Inc.
 TCM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology TCM Biosciences, Inc. engages in the provision of electrical diagnostic services. Its products include human papillomavirus self collection kit, sample preparation equipment, respiratory disease diagnosis, glizigen, cosmeceuticals, and medical devices. The company was founded on August 3, 2009 and is headquartered in Seongnam-si, South Korea. | Chief Executive Officer | - |
Ausbildung von Young-Chul Park
| Yonsei University | Doctorate Degree |
| Kyung Hee University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BL PHARMTECH CORP. | Process Industries |
| MOA LIFE PLUS CO. LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
TCM Biosciences, Inc.
TCM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology TCM Biosciences, Inc. engages in the provision of electrical diagnostic services. Its products include human papillomavirus self collection kit, sample preparation equipment, respiratory disease diagnosis, glizigen, cosmeceuticals, and medical devices. The company was founded on August 3, 2009 and is headquartered in Seongnam-si, South Korea. | Health Technology |
